Interpreting gene expression effects of disease-associated variants: A lesson from SNCA rs356168

Omolara Chinue Glenn, Lidia Tagliafierro, Thomas G. Beach, Randall (Randy) Woltjer, Ornit Chiba-Falek

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson's disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total SNCA-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of SNCA-mRNA levels in temporal brain tissues (p = 0.02) compared to individuals homozygous for the 'A' allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of SNCA SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of SNCA expression. The regulatory mechanisms that contribute to the observed associations between PD and the SNCA-3' linkage disequilibrium region warrant further investigations.

Original languageEnglish (US)
Article number133
JournalFrontiers in Genetics
Volume8
Issue numberSEP
DOIs
StatePublished - Sep 20 2017

Fingerprint

Alleles
Frontal Lobe
Gene Expression
Messenger RNA
Single Nucleotide Polymorphism
Parkinson Disease
Induced Pluripotent Stem Cells
Genome-Wide Association Study
Linkage Disequilibrium
Brain
Temporal Lobe
Genome
Neurons
Parkinson disease 3

Keywords

  • Gene expression
  • Parkinson's disease
  • SNCA gene
  • Translation of GWAS findings

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Cite this

Interpreting gene expression effects of disease-associated variants : A lesson from SNCA rs356168. / Glenn, Omolara Chinue; Tagliafierro, Lidia; Beach, Thomas G.; Woltjer, Randall (Randy); Chiba-Falek, Ornit.

In: Frontiers in Genetics, Vol. 8, No. SEP, 133, 20.09.2017.

Research output: Contribution to journalArticle

Glenn, Omolara Chinue ; Tagliafierro, Lidia ; Beach, Thomas G. ; Woltjer, Randall (Randy) ; Chiba-Falek, Ornit. / Interpreting gene expression effects of disease-associated variants : A lesson from SNCA rs356168. In: Frontiers in Genetics. 2017 ; Vol. 8, No. SEP.
@article{a7aa4b3d972a4925bc5a0f2a135a09c1,
title = "Interpreting gene expression effects of disease-associated variants: A lesson from SNCA rs356168",
abstract = "The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson's disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total SNCA-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of SNCA-mRNA levels in temporal brain tissues (p = 0.02) compared to individuals homozygous for the 'A' allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of SNCA SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of SNCA expression. The regulatory mechanisms that contribute to the observed associations between PD and the SNCA-3' linkage disequilibrium region warrant further investigations.",
keywords = "Gene expression, Parkinson's disease, SNCA gene, Translation of GWAS findings",
author = "Glenn, {Omolara Chinue} and Lidia Tagliafierro and Beach, {Thomas G.} and Woltjer, {Randall (Randy)} and Ornit Chiba-Falek",
year = "2017",
month = "9",
day = "20",
doi = "10.3389/fgene.2017.00133",
language = "English (US)",
volume = "8",
journal = "Frontiers in Genetics",
issn = "1664-8021",
publisher = "Frontiers Media S. A.",
number = "SEP",

}

TY - JOUR

T1 - Interpreting gene expression effects of disease-associated variants

T2 - A lesson from SNCA rs356168

AU - Glenn, Omolara Chinue

AU - Tagliafierro, Lidia

AU - Beach, Thomas G.

AU - Woltjer, Randall (Randy)

AU - Chiba-Falek, Ornit

PY - 2017/9/20

Y1 - 2017/9/20

N2 - The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson's disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total SNCA-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of SNCA-mRNA levels in temporal brain tissues (p = 0.02) compared to individuals homozygous for the 'A' allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of SNCA SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of SNCA expression. The regulatory mechanisms that contribute to the observed associations between PD and the SNCA-3' linkage disequilibrium region warrant further investigations.

AB - The SNCA intronic single nucleotide polymorphism (SNP), rs356168, has been associated with Parkinson's disease (PD) in large genome wide association studies (GWAS). Recently, the PD-risk allele, rs356168-G was shown to increase SNCA-mRNA expression using genome edited human induced pluripotent stem cells (iPSC)-derived neurons. In this study, as means of validation, we tested the effect of rs356168 on total SNCA-mRNA levels using brain tissues, temporal and frontal cortex, from healthy control donors. Carriers of the rs356168-G allele demonstrated a borderline significant decrease of SNCA-mRNA levels in temporal brain tissues (p = 0.02) compared to individuals homozygous for the 'A' allele. Similar trend, but weak, was observed in the analysis of frontal cortex samples, however, this analysis did not reach statistical significance. These results conflict with the recently reported effect of SNCA SNP rs356168 described above. Our study conveys the need to carefully interpret the precise molecular mechanism by which rs356168, or another tightly linked variant, affects the regulation of SNCA expression. The regulatory mechanisms that contribute to the observed associations between PD and the SNCA-3' linkage disequilibrium region warrant further investigations.

KW - Gene expression

KW - Parkinson's disease

KW - SNCA gene

KW - Translation of GWAS findings

UR - http://www.scopus.com/inward/record.url?scp=85030154198&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030154198&partnerID=8YFLogxK

U2 - 10.3389/fgene.2017.00133

DO - 10.3389/fgene.2017.00133

M3 - Article

AN - SCOPUS:85030154198

VL - 8

JO - Frontiers in Genetics

JF - Frontiers in Genetics

SN - 1664-8021

IS - SEP

M1 - 133

ER -